Generated by GPT-5-mini| CT scan | |
|---|---|
![]() FDA · Public domain · source | |
| Name | Computed tomography |
| Caption | Cross-sectional medical image |
| Purpose | Diagnostic imaging |
| Inventor | Godfrey Hounsfield; Allan Cormack |
| Year | 1970s |
| Specialty | Radiology |
CT scan
A computed tomography examination produces cross-sectional images of anatomical structures using X‑ray technology and computational reconstruction. Developed in the 1970s by Godfrey Hounsfield and Allan Cormack, the modality revolutionized diagnostic radiology by enabling detailed visualization of soft tissue, bone, and vascular anatomy. Modern systems integrate innovations from institutions such as Massachusetts Institute of Technology, GE Healthcare, Siemens Healthineers, and Philips to support trauma care at centers like Johns Hopkins Hospital, Mayo Clinic, and Massachusetts General Hospital.
Early predecessors include radiographic tomography efforts and mathematical foundations in linear algebra and inverse problems developed by figures associated with Cambridge University and University of Cape Town. The first clinical unit arose at Atkinson Morley's Hospital under the work of Godfrey Hounsfield and engineering teams at EMI; concurrently, computational approaches from Allan Cormack at Tufts University and University of Cape Town provided the theoretical basis. Rapid adoption followed regulatory clearances and installations at centers such as Mayo Clinic and Royal London Hospital, while later milestones included spiral CT, multislice detectors from Cleveland Clinic collaborators, and the integration of helical acquisition developed by industrial groups at Siemens. Key awards recognizing the invention include the Nobel Prize in Physiology or Medicine shared by Hounsfield and Cormack.
CT systems combine an X‑ray tube and detector array mounted on a gantry that rotates around a patient couch designed by medical device engineers at companies like GE Healthcare and Philips. Reconstruction algorithms draw on work from numerical analysts at Massachusetts Institute of Technology and Stanford University, including filtered back projection and iterative reconstruction methods pioneered with contributions from Harvard University groups. Modern advances incorporate multislice detector rows originated at research labs affiliated with Cleveland Clinic and parallel computing using processors from Intel and NVIDIA to accelerate cone‑beam geometry reconstructions. Quantitative parameters use the Hounsfield scale, named for Godfrey Hounsfield, to standardize attenuation values for tissues and contrast agents developed by pharmaceutical firms such as Bayer and GE Healthcare.
CT is essential in acute settings like trauma bays at institutions such as Royal London Hospital and St Thomas' Hospital for rapid assessment of intracranial hemorrhage, thoracoabdominal injury, and pelvic fractures. It is widely used in oncology centers including MD Anderson Cancer Center and University of Texas MD Anderson Cancer Center for staging of lung, liver, pancreatic, and colorectal cancers and for planning radiotherapy in conjunction with departments at Memorial Sloan Kettering Cancer Center. Cardiac CT for coronary artery assessment is implemented at specialized units such as Cleveland Clinic and Mount Sinai Hospital, while pulmonary embolism detection is routine in emergency departments like Guy's and St Thomas' NHS Foundation Trust. CT angiography supports vascular surgery teams at Mayo Clinic and interventional radiology divisions at Johns Hopkins Hospital.
Scheduling and informed consent commonly follow institutional protocols at hospitals like Mayo Clinic and Massachusetts General Hospital. Patient screening for contraindications often references guidance from bodies such as the U.S. Food and Drug Administration and the World Health Organization. Preparation may include fasting advised by perioperative services at Cleveland Clinic, review of renal function with laboratory departments at Johns Hopkins Hospital when iodinated contrast from suppliers like Bayer is planned, and removal of metallic objects per radiography policies at Royal Infirmary of Edinburgh. Pediatric protocols are influenced by recommendations from American Academy of Pediatrics and pediatric radiology units at Great Ormond Street Hospital.
Radiation dose considerations derive from standards set by organizations including the International Commission on Radiological Protection and U.S. Nuclear Regulatory Commission. Contrast‑induced nephropathy and allergic reactions to iodinated media are managed according to guidelines from American College of Radiology and emergency departments at Johns Hopkins Hospital. Dose‑reduction strategies such as automatic exposure control were developed in collaboration with engineering groups at Siemens Healthineers and GE Healthcare, while shielding and justification protocols are adopted from recommendations by World Health Organization and national regulators like the Food and Drug Administration.
Image interpretation is performed by radiologists trained in residency programs accredited by organizations such as the Royal College of Radiologists and the American Board of Radiology. Structured reporting templates and communication standards often reference initiatives from RadLex and professional societies including the European Society of Radiology and American College of Radiology. Multidisciplinary review occurs in tumor boards at centers such as MD Anderson Cancer Center and Memorial Sloan Kettering Cancer Center where CT findings inform treatment decisions by oncologists, surgeons, and radiotherapists.
Active research directions involve photon‑counting detectors developed with academic‑industry partnerships involving University of Oslo groups and companies like Siemens Healthineers, machine learning reconstruction and diagnostic assistance from teams at Google Health and DeepMind, and low‑dose protocols informed by trials at National Institutes of Health. Integration with hybrid modalities such as positron emission tomography in collaborations between UCLA and Stanford University promises enhanced molecular characterization, while multicenter trials coordinated by networks like European Organisation for Research and Treatment of Cancer explore applications in precision oncology.